Prostate-specific antigen decline after casodex withdrawal: evidence for an antiandrogen withdrawal syndrome.
To evaluate the relationship between antiandrogen withdrawal and change in prostate-specific antigen (PSA) when the antiandrogen in question is other than flutamide. Presented is a case of a patient in whom the antiandrogen casodex was discontinued after clinical progression despite combined androgen blockade. A transient decline in serum PSA was observed after casodex withdrawal. The relationship between antiandrogen withdrawal and a change in PSA may be a general phenomenon, not unique to flutamide.